COST

1,094.69

+1.76%↑

81.91

+0.85%↑

141.32

-0.73%↓

191.62

+0.04%↑

PEP

150.44

+0.88%↑

COST

1,094.69

+1.76%↑

81.91

+0.85%↑

141.32

-0.73%↓

191.62

+0.04%↑

PEP

150.44

+0.88%↑

COST

1,094.69

+1.76%↑

81.91

+0.85%↑

141.32

-0.73%↓

191.62

+0.04%↑

PEP

150.44

+0.88%↑

COST

1,094.69

+1.76%↑

81.91

+0.85%↑

141.32

-0.73%↓

191.62

+0.04%↑

PEP

150.44

+0.88%↑

COST

1,094.69

+1.76%↑

81.91

+0.85%↑

141.32

-0.73%↓

191.62

+0.04%↑

PEP

150.44

+0.88%↑

Home・Aktien・Lifecore Biomedical Inc

Lifecore Biomedical Inc

Geschlossen

BrancheKonsumgüter defensiv

4.36 -0.23

Buy Sell

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

4.17

Max

4.51

Schlüsselkennzahlen
By Trading Economics
Einkommen	-8.9M -15M
Verkäufe	-7.9M 23M
Gewinnspanne	-64.588
Angestellte	382

Empfehlungen
By TipRanks
Empfehlungen	Starkes Kaufsignal
12-Monats-Prognose	+52.28% upside

Marktstatistiken
By TradingEconomics
Marktkapitalisierung	-102M 139M
Vorheriger Eröffnungskurs	4.59
Vorheriger Schlusskurs	4.36

Nachrichtenstimmung

By Acuity

50%

74 / 131 Ranking in Consumer defensive

Lifecore Biomedical Inc Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Ähnliche Nachrichten

19. Mai 2026, 20:36 UTC

Akquisitionen, Fusionen, Übernahmen

Analog Devices to Buy Empower Semiconductor for $1.5 Billion

19. Mai 2026, 23:47 UTC

Market Talk

Nikkei May Decline as Concerns About Energy, Material Costs Persists -- Market Talk

19. Mai 2026, 23:34 UTC

Market Talk

Gold Edges Higher on Possible Technical Recovery -- Market Talk

19. Mai 2026, 23:28 UTC

Market Talk

Ergebnisse

Global Forex and Fixed Income Roundup: Market Talk

19. Mai 2026, 23:28 UTC

Market Talk

Ergebnisse

F&P Healthcare's Outlook Key for Investors -- Market Talk

19. Mai 2026, 23:10 UTC

Market Talk

Global Equities Roundup: Market Talk

19. Mai 2026, 23:10 UTC

Market Talk

Kiwi Property's Dividend Growth Reliant on Several Factors -- Market Talk

19. Mai 2026, 22:02 UTC

Ergebnisse

ZTO Express (Cayman): Di Xu to Resign From Board

19. Mai 2026, 22:01 UTC

Ergebnisse

ZTO Express (Cayman) 1Q Adj EPS 43c >ZTO

19. Mai 2026, 22:01 UTC

Ergebnisse

ZTO Express (Cayman) 1Q EPS 39c >ZTO

19. Mai 2026, 22:00 UTC

Ergebnisse

ZTO Express (Cayman) 1Q Rev $1.93B >ZTO

19. Mai 2026, 21:37 UTC

Ergebnisse

Cracks Are Starting to Appear in the Chip Stock Rally -- Barrons.com

19. Mai 2026, 21:31 UTC

Akquisitionen, Fusionen, Übernahmen

How NextEra Can Fix Dominion's Strange AI Problem -- Barrons.com

19. Mai 2026, 21:01 UTC

Ergebnisse

Home Depot Beats Earnings Estimates as Shoppers Defy Inflation Fears. The Stock Advances. -- Barrons.com

19. Mai 2026, 20:58 UTC

Ergebnisse

These Stocks Are Today's Movers: CoreWeave, Nvidia, Home Depot, Akamai, Agilysys, Micron, and More -- Barrons.com

19. Mai 2026, 20:46 UTC

Heiße Aktien

Stocks to Watch Recap: ServiceNow, Home Depot, CoreWeave -- WSJ

19. Mai 2026, 20:43 UTC

Market Talk

Canada 30-Year Yield Hits Highest Level Since 2010 -- Market Talk

19. Mai 2026, 20:34 UTC

Ergebnisse

James Hardie Industries Sees FY27 Sales $5.25B-$5.41B >JHX

19. Mai 2026, 20:32 UTC

Ergebnisse

James Hardie Industries: Targeting Pro Forma Adjusted EBITDA Growth of 4% to 8% in FY27 >JHX

19. Mai 2026, 20:32 UTC

Ergebnisse

James Hardie Industries 4Q EPS 5c >JHX

19. Mai 2026, 20:32 UTC

Ergebnisse

James Hardie Industries 4Q Sales $1.4B >JHX

19. Mai 2026, 20:21 UTC

Akquisitionen, Fusionen, Übernahmen

Analog Devices to Buy Empower Semiconductor for $1.5B

19. Mai 2026, 20:18 UTC

Market Talk

Canada CPI Data Has Accounting Quirk Related to Travel Tours -- Market Talk

19. Mai 2026, 20:13 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

19. Mai 2026, 20:13 UTC

Market Talk

'Hard to Square' Canada Rate Hikes Expectations Given Mild Core -- Market Talk

19. Mai 2026, 20:03 UTC

Akquisitionen, Fusionen, Übernahmen

Analog Devices: Deal Further Advances Position as Strategic, System-Level Grid-To-Core Power Partner for Hyperscalers, AI Silicon Developers >ADI

19. Mai 2026, 20:03 UTC

Akquisitionen, Fusionen, Übernahmen

Analog Devices: Phillips Will Continue Leading IVR Technology Efforts as Part of ADI >ADI

19. Mai 2026, 20:02 UTC

Akquisitionen, Fusionen, Übernahmen

Analog Devices Will Acquire Empower in All-Cash Transaction for $1.5 B >ADI

19. Mai 2026, 20:02 UTC

Akquisitionen, Fusionen, Übernahmen

Analog Devices to Acquire Empower Semiconductor, Expanding Its Next-Generation High-Density Power Portfolio for the AI Era

19. Mai 2026, 19:23 UTC

Market Talk

Oil Futures Slip With Market Back on U.S.-Iran Deal Watch -- Market Talk

Peer-Vergleich

Kursveränderung

Lifecore Biomedical Inc Prognose

Kursziel

By TipRanks

52.28% Vorteil

12-Monats-Prognose

Durchschnitt 6.67 USD 52.28%

Hoch 9 USD

Tief 5 USD

Basierend auf 4 Wall-Street-Analysten, die in den letzten 3 Monaten 12-Monats-Kursziele für Lifecore Biomedical Inc – Dist angeboten haben.

Rating-Konsens

By TipRanks

Starkes Kaufsignal

4 ratings

Buy

Halten

Sell

Basierend auf 4 Analysten, die in den letzten 3 Monaten Aktienbewertungen für Lifecore Biomedical Inc – Dist abgegeben haben.

Stimmung

By Acuity

74 / 131 Ranking in Konsumgüter defensiv

Finanzen

Vertriebs- und Verwaltungskosten

Betriebsaufwand

Gewinn vor Steuern

Verkäufe

Umsatzkosten

Bruttogewinn aus dem Verkauf

Zinsaufwand für Schulden

EBITDA

Betriebsergebnis

Über Lifecore Biomedical Inc

Lifecore Biomedical, Inc., together with its subsidiaries, operates as an integrated contract development and manufacturing organization in the United States. The company engages in the manufacturing of injectable grade sodium hyaluronate (HA) in bulk form, as well as formulated and filled syringes and vials for injectable products used in treating a range of medical conditions and procedures. It also provides services, such as technology development, material component changes, analytical method development, formulation development, pilot studies, stability studies, process validation, and production of materials for clinical studies to its partners for HA-based and non-HA based aseptically formulated and filled products. The company was formerly known as Landec Corporation and changed its name to Lifecore Biomedical, Inc. in November 2022. Lifecore Biomedical, Inc. was founded in 1965 and is headquartered in Chaska, Minnesota.